Shi-Fang Yan

Title: Innovations by Shi-Fang Yan in Vascular Injury Reduction

Introduction

Shi-Fang Yan is an accomplished inventor based in New York, NY (US). She has made significant contributions to the field of medical science, particularly in methods aimed at reducing vascular injury. Her innovative approach focuses on the inhibition of Early Growth Response Factor-1 Protein (Egr-1), which plays a crucial role in tissue damage during ischemic events.

Latest Patents

Shi-Fang Yan holds a patent for her invention titled "Methods for suppressing early growth response—1 protein (Egr-1) to reduce vascular injury in a subject." This patent outlines a method for reducing damage to ischemic tissue by contacting the cells with an inhibitor of Egr-1. The invention also details a process for minimizing vascular injury during reperfusion of ischemic tissue by using a compound that inhibits Egr-1 expression. This innovative method is particularly beneficial for subjects who have suffered strokes, myocardial infarctions, or are undergoing various surgical procedures.

Career Highlights

Shi-Fang Yan is affiliated with Columbia University, where she continues her research and development in the medical field. Her work has garnered attention for its potential to improve patient outcomes in critical situations involving vascular injuries. With her expertise, she has contributed to advancing medical knowledge and treatment options.

Collaborations

Shi-Fang Yan has collaborated with notable colleagues, including David J Pinsky and David M Stern. These partnerships have further enriched her research and have led to significant advancements in understanding vascular injuries and their treatment.

Conclusion

Shi-Fang Yan's innovative work in reducing vascular injury through the inhibition of Egr-1 represents a significant advancement in medical science. Her contributions not only highlight her expertise but also pave the way for improved therapeutic strategies in treating ischemic conditions.